assurant inc. - AIZ
AIZ
Close Chg Chg %
201.47 1.99 0.99%
Closed Market
203.46
+1.99 (0.99%)
Volume: 390.33K
Last Updated:
Jun 6, 2025, 3:59 PM EDT
Company Overview: assurant inc. - AIZ
AIZ Key Data
Open $203.41 | Day Range 202.26 - 204.31 |
52 Week Range 160.33 - 230.49 | Market Cap $10.21B |
Shares Outstanding 50.70M | Public Float 50.24M |
Beta 0.60 | Rev. Per Employee N/A |
P/E Ratio 15.70 | EPS $12.91 |
Yield 150.94% | Dividend $0.80 |
EX-DIVIDEND DATE Jun 9, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 816.18K |
AIZ Performance
1 Week | 0.24% | ||
1 Month | 3.97% | ||
3 Months | -0.54% | ||
1 Year | 17.38% | ||
5 Years | 77.12% |
AIZ Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
9
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 229.60 | |
Number of Ratings | 9 | Current Quarters Estimate | 4.522 | |
FY Report Date | 06 / 2025 | Current Year's Estimate | 16.448 | |
Last Quarter’s Earnings | 3.39 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 16.64 | Next Fiscal Year Estimate | 19.475 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 7 | 6 | 7 | 7 |
Mean Estimate | 4.52 | 3.77 | 16.45 | 19.47 |
High Estimates | 4.80 | 4.11 | 17.25 | 20.70 |
Low Estimate | 4.17 | 3.36 | 15.37 | 18.75 |
Coefficient of Variance | 4.75 | 7.91 | 3.46 | 3.52 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 5 | 5 | 4 |
OVERWEIGHT | 2 | 2 | 2 |
HOLD | 2 | 2 | 3 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Assurant Inc. - AIZ
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Assurant Inc. - AIZ
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
May 20, 2025 | Jay E. Rosenblum EVP and CLO | 11,775 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $201.93 per share | 2,377,725.75 |
Apr 4, 2025 | Biju Nair EVP | 19,610 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.56 per share | 4,148,691.60 |
Mar 25, 2025 | Robert A. Lonergan Chief Marketing & Risk Officer | 25,731 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $212.39 per share | 5,465,007.09 |
Mar 25, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 4,085 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $213.03 per share | 870,227.55 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 87,929 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 18,570,604.80 |
Mar 21, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 5,735 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 1,211,232.00 |
Mar 21, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 6,032 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 4,990 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 1,053,888.00 |
Mar 21, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 5,046 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 1,065,715.20 |
Mar 21, 2025 | Dimitry DiRienzo SVP, CAO, Controller | 5,103 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 1,077,753.60 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 102,605 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 21,670,176.00 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 115,788 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 86,323 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 18,231,417.60 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 90,113 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 19,031,865.60 |
Mar 21, 2025 | Keith Warner Demmings President and CEO; Director | 91,183 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2025 | Jeffrey A Strickland EVP | 4,163 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 879,225.60 |
Mar 21, 2025 | Jay E. Rosenblum EVP and CLO | 12,775 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 2,698,080.00 |
Mar 21, 2025 | Jay E. Rosenblum EVP and CLO | 14,964 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 21, 2025 | Jay E. Rosenblum EVP and CLO | 9,859 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 2,082,220.80 |
Mar 21, 2025 | Jay E. Rosenblum EVP and CLO | 10,093 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $211.2 per share | 2,131,641.60 |